Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropeptide Y receptor subtypes

C P Wan1, B H Lau

  • 1Department of Microbiology and Molecular Genetics, School of Medicine, Loma Linda University, CA 92350, USA.

Life Sciences
|February 17, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pycnogenol enhances endothelial cell antioxidant defenses.

Redox report : communications in free radical research·2016
Same author

Removal of batteries from solid waste using trommel separation.

Waste management (New York, N.Y.)·2005
Same author

Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage.

Drug development and industrial pharmacy·2004
Same author

Antioxidant effects of fructosyl arginine, a Maillard reaction product in aged garlic extract.

The Journal of nutritional biochemistry·2004
Same author

Herpes zoster during varicella.

The Pediatric infectious disease journal·2001
Same author

S-allyl cysteine reduces oxidant load in cells involved in the atherogenic process.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2001
Same journal

Corrigendum to "Adipose stem cells-derived microvesicles and chicken egg-derived exosomes attenuate cardiac ischemia/reperfusion injury through AKT/ERK/Nrf2/HO-1 axis to inhibit apoptosis and inflammation and restore autophagy" [Life Sci. 395 (2026) 124364].

Life sciences·2026
Same journal

MAGED1 stabilizes NEUROD1 to promote Per3 expression in the pineal gland.

Life sciences·2026
Same journal

TNF-centered network pharmacology and molecular modeling of selected Andrographis paniculata compounds in hypertension.

Life sciences·2026
Same journal

Retraction notice to "Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat" [Life Sci. 113 (2014) 22-30].

Life sciences·2026
Same journal

Soluble PD-1 drives renal fibrosis in CKD by disrupting immune homeostasis: Therapeutic mitigation via a targeted sPD-1 sequestration strategy.

Life sciences·2026
Same journal

METTL1 promotes hepatic steatosis by mediating m<sup>7</sup>G modification of ALOX15B mRNA.

Life sciences·2026
See all related articles

Neuropeptide Y (NPY) receptors, including Y1, Y2, and Y3, are involved in diverse physiological responses. Research indicates potential interactions with other receptors and signaling pathways, though specific subtype links remain unclear.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Neuropeptide Y (NPY) is a 36-amino acid peptide found throughout the nervous system.
  • NPY elicits physiological responses by activating specific receptors.
  • Existing research suggests multiple NPY receptor subtypes with varying binding affinities.

Purpose of the Study:

  • To review the known subtypes of Neuropeptide Y receptors.
  • To explore the signaling mechanisms and interactions of NPY receptors.
  • To identify gaps in the current understanding of NPY receptor function.

Main Methods:

  • Literature review of studies on NPY analogs and receptor binding.
  • Analysis of data from various model systems and cell types.
  • Examination of ligand binding and signal transduction pathway investigations.

Related Experiment Videos

Main Results:

  • NPY binds to at least three receptors: Y1, Y2, and Y3, which are G-protein coupled.
  • NPY also interacts with sigma receptors, with G-protein coupling status unconfirmed.
  • Potential interactions with alpha- and beta-adrenoceptors and cholinergic receptors are indicated.

Conclusions:

  • NPY receptors are linked to diverse signal transduction pathways, including adenylate cyclase inhibition and modulation of intracellular Ca2+.
  • Specific associations between individual NPY receptor subtypes and particular signaling pathways require further elucidation.
  • The complexity of NPY receptor interactions suggests a broad physiological role requiring continued investigation.